UnitedHealth Group Incorporated (NYSE:UNH) Stake Increased by Elevated Capital Advisors LLC

Elevated Capital Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 43.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,151 shares of the healthcare conglomerate’s stock after acquiring an additional 350 shares during the period. Elevated Capital Advisors LLC’s holdings in UnitedHealth Group were worth $582,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $27,000. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $32,000. Quarry LP raised its stake in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Barclays lifted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $626.79.

View Our Latest Analysis on UNH

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $541.28 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $498.13 billion, a price-to-earnings ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $554.92 and its 200 day simple moving average is $562.88.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.